Schedule 13G ownership disclosure

SILEXION THERAPEUTICS CORP

Ordinary shares, par value $0.0135 per share · CUSIP: G1281K122

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Lind Global Fund III LP

    Shares: 212,500 · Class: 6.4%

  • Lind Global Partners III LLC

    Shares: 212,500 · Class: 6.4%

  • EASTON JEFF

    Shares: 212,500 · Class: 6.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-25-004297
Form type
SCHEDULE 13G/A
Filer
Lind Global Fund III LP
CIK
CIK 2071860
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub